Castleark Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-127,460	Closed	-$3.91M	–	293
2022 Q3	$3.91M	Buy	+127,460	New	+$3.91M	0.22%	119
2021 Q4	–	Sell	-66,145	Closed	-$3.34M	–	339
2021 Q3	$3.34M	Buy	66,145 +37,105	+128%	+$1.87M	0.13%	158
2021 Q2	$2.28M	Buy	+29,040	New	+$2.28M	0.08%	187